{"id":"https://openalex.org/W2017090735","doi":"https://doi.org/10.1016/j.toxlet.2011.05.246","title":"Survey of minipig clinical chemistry, haematology, coagulation, and urinalysis parameters in the European pharmaceutical industry\u2014Current practice and challenges for the future development of biomarkers of toxicity in the minipig","display_name":"Survey of minipig clinical chemistry, haematology, coagulation, and urinalysis parameters in the European pharmaceutical industry\u2014Current practice and challenges for the future development of biomarkers of toxicity in the minipig","publication_year":2011,"publication_date":"2011-07-26","ids":{"openalex":"https://openalex.org/W2017090735","doi":"https://doi.org/10.1016/j.toxlet.2011.05.246","mag":"2017090735"},"language":"en","primary_location":{"id":"doi:10.1016/j.toxlet.2011.05.246","doi":"https://doi.org/10.1016/j.toxlet.2011.05.246","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.toxlet.2011.05.246","pdf_url":null,"source":{"id":"https://openalex.org/S205878144","display_name":"Toxicology Letters","issn_l":"0378-4274","issn":["0378-4274","1879-3169"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034502895","display_name":"Niels\u2010Christian Ganderup","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"N.C. Ganderup","raw_affiliation_strings":["Ellegaard G\u00f6ttingen Minipigs, Dalmose, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ellegaard G\u00f6ttingen Minipigs, Dalmose, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109278092","display_name":"Lesley K. Earl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Earl","raw_affiliation_strings":["Huntongdon Life Science, Alconbury, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntongdon Life Science, Alconbury, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114110944","display_name":"Cl\u00e9ment Bouchez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Bouchez","raw_affiliation_strings":["CIT, Evreux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIT, Evreux, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032422361","display_name":"Sofiene Mhedhbi","orcid":"https://orcid.org/0000-0002-0931-5143","observed_orcids":["https://orcid.org/0000-0002-0931-5143"]},"institutions":[{"id":"https://openalex.org/I4210120458","display_name":"Galderma (France)","ror":"https://ror.org/034kxvk28","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210120458","https://openalex.org/I4210163806"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S. Mhedhbi","raw_affiliation_strings":["Galderma, Sophia Antipolis, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma, Sophia Antipolis, France","institution_ids":["https://openalex.org/I4210120458"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017594782","display_name":"Andy Gibbs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166171","display_name":"Covance (United Kingdom)","ror":"https://ror.org/059vag305","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210166171","https://openalex.org/I60638368"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Gibbs","raw_affiliation_strings":["Covance, Harrogate, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance, Harrogate, UK","institution_ids":["https://openalex.org/I4210166171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039503394","display_name":"Peter Glerup","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Glerup","raw_affiliation_strings":["LAB Research (Scantox), Lille Skensved, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LAB Research (Scantox), Lille Skensved, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065155891","display_name":"Gabi Itter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"G. Itter","raw_affiliation_strings":["Sanofi Aventis, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Aventis, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004046770","display_name":"Peter Clausing","orcid":"https://orcid.org/0000-0003-3484-4984","observed_orcids":["https://orcid.org/0000-0003-3484-4984"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Clausing","raw_affiliation_strings":["Private, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Private, Berlin, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5034502895"],"corresponding_institution_ids":[],"apc_list":{"value":4270,"currency":"USD","value_usd":4270},"apc_paid":null,"fwci":0.9136,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.73204826,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"205","issue":null,"first_page":"S63","last_page":"S63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.9136000275611877,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.051500000059604645,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/miniature-pigs","display_name":"minipigs","score":0.8949999809265137},{"id":"https://openalex.org/keywords/clinical-chemistry","display_name":"clinical chemistry","score":0.7300000190734863},{"id":"https://openalex.org/keywords/hematology","display_name":"hematology","score":0.9909999966621399},{"id":"https://openalex.org/keywords/blood-coagulation","display_name":"coagulation","score":0.9409999847412109},{"id":"https://openalex.org/keywords/urine-analysis","display_name":"urine analysis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/toxicity-biomarkers","display_name":"biomarkers of toxicity","score":0.843999981880188},{"id":"https://openalex.org/keywords/animal-disease-surveillance","display_name":"animal health monitoring","score":0.4350000023841858},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.5180000066757202},{"id":"https://openalex.org/keywords/nonclinical-toxicology","display_name":"nonclinical toxicology","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C2779225474","wikidata":"https://www.wikidata.org/wiki/Q842424","display_name":"Urinalysis","level":3,"score":0.870590090751648},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.5022373199462891},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.4942009747028351},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.481579065322876},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.47310519218444824},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45147716999053955},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.43655073642730713},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3534197211265564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3352566957473755},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.13931870460510254},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.12232756614685059}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.toxlet.2011.05.246","doi":"https://doi.org/10.1016/j.toxlet.2011.05.246","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.toxlet.2011.05.246","pdf_url":null,"source":{"id":"https://openalex.org/S205878144","display_name":"Toxicology Letters","issn_l":"0378-4274","issn":["0378-4274","1879-3169"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2334802051","https://openalex.org/W94916691","https://openalex.org/W1971173214","https://openalex.org/W2596749901","https://openalex.org/W4386479892","https://openalex.org/W3204489430","https://openalex.org/W2917476672","https://openalex.org/W2478375946","https://openalex.org/W2073176915","https://openalex.org/W4248960255"],"abstract_inverted_index":null,"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
